GoKawiilResearch continues into side effects of popular GLP-1 weight-loss drugs
GLP-1 agonist drugs, approved for diabetes, kidney disease and obesity, are being used by a growing share of Americans, with a recent Gallup poll finding 11% currently take one for weight loss, up from 3% in 2024. Beyond common gastrointestinal issues, pancreatitis and gallstones, researchers and lawsuits are examining rarer possible effects including eye nerve damage, plus emerging questions about hair and nail changes.